Post by Wörwag Pharma GmbH & Co. KG

Celebrating Excellence in Biofactor Research! This past Saturday, we were proud to present the 11th Dr. Fritz-Wörwag Research Prize 2024/25, honoring outstanding achievements in biofactor research - an area essential for maintaining health and preventing disease. 🏆 Main Prize Congratulations to Dr. Sandra Habicht (Justus Liebig University Giessen) on her systematic review and meta-analysis of the effects of coenzyme Q10 supplementation on statin-associated muscle symptoms (SAMS). Her work provides valuable insights into how targeted coenzyme Q10 supplementation can improve quality of life for patients on statin therapy. 🔬 Special Prize – Personalized Diagnostics We also congratulate Prof. Dr. Markus Herrmann (Medical University of Graz) for his innovative approach to personalized Vitamin D diagnostics, showing how functional assessment can improve diagnostic accuracy and patient outcomes. The Dr. Fritz‑Wörwag Research Prize, established by our company founder Dr. Fritz Wörwag, supports scientific progress in biofactor research and encourages breakthroughs that make a real difference for people’s health. At Wörwag Pharma, we remain committed to advancing therapies for lifestyle-related diseases through evidence-based, biofactor-driven solutions. 👉 Learn more about our mission: www.woerwagpharma.com #BiofactorResearch #InnovationInHealthcare #WörwagPharma #ResearchPrize #PersonalizedMedicine